Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEJS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,394
Award facts
- Contract value 100% obligated
- $28,393.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,393.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL syringes. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499.999 billion through November 2026. The contract does not utilize a set-aside designation, allowing the company to compete on an unrestricted basis leveraging its woman-owned small business status.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, specializing in delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Nucala, a specialty pharmaceutical product, represents one of the diverse range of medications and injectables the company supplies through its IDC with DLA. With over two decades of SAM.gov registration and a robust portfolio of pharmaceutical delivery orders, DMS Pharmaceutical Group continues to support military health facility operations through the efficient distribution of essential medications and medical supplies.
Quick answers
Who was awarded contract SPE2DB25FKEJS?
SPE2DB25FKEJS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FKEJS worth?
The government has obligated $28,394 on SPE2DB25FKEJS.
Is contract SPE2DB25FKEJS an order under another contract?
Yes. SPE2DB25FKEJS is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJS competed?
The extent of competition for SPE2DB25FKEJS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award